Hasil Pencarian - Andrew S. Duncombe

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Circulating promastocytes and atypical mast cells in systemic mastocytosis associated with acute myelogenous leukaemia transformation

    Circulating promastocytes and atypical mast cells in systemic mastocytosis associated with acute myelogenous leukaemia transformation oleh Mohammed O. A. Altohami, Dana Lewis, Andrew S. Duncombe

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Glioblastoma, IDH-wildtype: A New Association with IgM Paraproteinaemic Neuropathy?

    Glioblastoma, IDH-wildtype: A New Association with IgM Paraproteinaemic Neuropathy? oleh Dana M. Lewis, Nancy T.H. Colchester, David Allen, James A.R. Nicoll, Haider A. Katifi, Andrew S. Duncombe

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Chemoimmunotherapy with rituximab, cyclophosphamide and prednisolone in IgM paraproteinaemic neuropathy: evidence of sustained improvement in electrophysiological, serological and functional outcomes

    Chemoimmunotherapy with rituximab, cyclophosphamide and prednisolone in IgM paraproteinaemic neuropathy: evidence of sustained improvement in electrophysiological, serological and... oleh Nancy T.H. Colchester, David Allen, Haider A. Katifi, Tracy Burt, Robert N. Lown, Ashwin A. Pinto, Andrew S. Duncombe

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Modifiable Lifestyle and Medical Risk Factors Associated With Myeloproliferative Neoplasms

    Modifiable Lifestyle and Medical Risk Factors Associated With Myeloproliferative Neoplasms oleh Andrew S. Duncombe, Lesley A. Anderson, Glen James, Frank de Vocht, Lin Fritschi, Ruben Mesa, Mike Clarke, Mary Frances McMullin

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    The JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden

    The JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden oleh Lai Yee Orbell, Nouf Abutheraa, Andrew S Duncombe, Mary Frances McMullin, Ruben Mesa, Charlene M McShane, Glen James, Lesley A Anderson

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    A hyperinflammation clinical risk tool, HI5-NEWS2, stratifies hospitalised COVID-19 patients to associate risk of death and effect of early dexamethasone in an observational cohort.

    A hyperinflammation clinical risk tool, HI5-NEWS2, stratifies hospitalised COVID-19 patients to associate risk of death and effect of early dexamethasone in an observational cohort... oleh Michael R Ardern-Jones, Hang T T Phan, Florina Borca, Matt Stammers, James Batchelor, Isabel C Reading, Sophie V Fletcher, Trevor Smith, Andrew S Duncombe

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: